Unraveling Targetable Systemic and Cell-Type-Specific Molecular Phenotypes of Alzheimer’s and Parkinson’s Brains With Digital Cytometry
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most common neurodegenerative disorders worldwide, with age being their major risk factor. The increasing worldwide life expectancy, together with the scarcity of available treatment choices, makes it thus pressing to find the molecul...
Main Authors: | Marie C. Bordone, Nuno L. Barbosa-Morais |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2020.607215/full |
Similar Items
-
New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
by: Airton Cunha Martins, et al.
Published: (2019-09-01) -
Unraveling neuroprotective and neurodegenerative signals
by: Irving E Vega, et al.
Published: (2016-07-01) -
Deciphering and manipulating the epigenome for the treatment of Parkinson’s and Alzheimer’s disease
by: Chidiebere Emmanuel Okechukwu
Published: (2021-01-01) -
Fetal programming of Parkinson’s and Alzheimer’s diseases: the role of epigenetic factors
by: Monica Piras, et al.
Published: (2014-10-01) -
Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways
by: Pranav Preman, et al.
Published: (2021-03-01)